Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
46.88
-1.48 (-3.06%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,8782,3001,3235371,632867
Upgrade
Market Cap Growth
73.94%73.94%146.40%-67.12%88.22%352.15%
Upgrade
Enterprise Value
2,3551,7281,0022741,286674
Upgrade
Last Close Price
48.3638.6022.9310.9134.2020.16
Upgrade
PE Ratio
11.438.36----
Upgrade
PS Ratio
6.855.3022.0420.1959.6730.29
Upgrade
PB Ratio
4.373.413.932.495.443.10
Upgrade
P/TBV Ratio
3.413.413.932.495.443.10
Upgrade
P/FCF Ratio
15.8812.59----
Upgrade
P/OCF Ratio
15.7712.49----
Upgrade
EV/Sales Ratio
5.423.9816.6910.2947.0123.53
Upgrade
EV/EBITDA Ratio
9.286.81----
Upgrade
EV/EBIT Ratio
9.316.84----
Upgrade
EV/FCF Ratio
12.889.45----
Upgrade
Debt / Equity Ratio
0.020.020.000.020.020.02
Upgrade
Debt / EBITDA Ratio
0.040.04----
Upgrade
Debt / FCF Ratio
0.060.06----
Upgrade
Asset Turnover
0.790.790.200.090.080.12
Upgrade
Quick Ratio
12.3912.3916.547.617.557.69
Upgrade
Current Ratio
12.4812.4816.717.807.747.84
Upgrade
Return on Equity (ROE)
54.39%54.39%-28.59%-49.41%-43.32%-36.79%
Upgrade
Return on Assets (ROA)
28.66%28.66%-19.32%-27.57%-23.40%-16.82%
Upgrade
Return on Capital (ROIC)
30.86%30.86%-21.01%-31.27%-26.60%-21.08%
Upgrade
Return on Capital Employed (ROCE)
36.30%36.30%----
Upgrade
Earnings Yield
9.48%11.96%-5.97%-23.73%-7.69%-7.63%
Upgrade
FCF Yield
6.30%7.95%-5.36%-20.29%-6.68%-8.41%
Upgrade
Buyback Yield / Dilution
-14.65%-14.65%-15.74%-5.87%-34.67%-32.84%
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q